Blog
Cannabis business growth depends on choosing directory options that match your audience; you should compare reach, listing features, reputation, and analytics to maximize sustained visibility and customer acquisition over time. Evaluating High-Traffic Consumer Platforms You should prioritize platforms with high organic traffic, targeted audiences, and clear conversion paths; these deliver steady consumer leads and measurable […]
Most cannabis businesses build trust through well-crafted directory listings; you should provide accurate details, high-quality photos, verified reviews, clear licensing information, and consistent branding to attract customers and appear professional. Selecting High-Authority Cannabis Directories Choosing directories with established editorial standards and clear verification processes strengthens your credibility; you should prioritize sites that enforce compliance, display […]
If you own a CBD store, being visible online isn't optional anymore - it's essential. While word-of-mouth and local foot traffic matter, most customers now discover businesses through search engines and online directories. Learn why getting your CBD store listed should be a top priority and how directory listings with do-follow links can transform your digital marketing strategy.
A bipartisan group of U.S. senators has introduced legislation that would postpone a looming federal ban on hemp THC products, providing crucial breathing room for an industry facing regulatory uncertainty. The Legislative Effort Sens. Amy Klobuchar (D-MN), Rand Paul (R-KY), and Jeff Merkley (D-OR) have filed a bill that would delay the enactment of a […]
On December 28, 2025, two parallel developments highlighted the complex interplay between cannabis regulation, workplace safety, and medical science. The Department of Transportation confronted potential road safety challenges as marijuana moves toward Schedule III classification, while an Oregon Health & Science University-led systematic review provided new evidence about cannabis efficacy for chronic pain management. DOT’s […]
A historic shift in federal drug policy is underway. Following an executive order signed on December 18, 2025, the Trump administration has directed an expedited move to reclassify cannabis from Schedule I to Schedule III. This monumental decision is set to reshape the industry by dismantling long-standing financial barriers and introducing first-of-its-kind federal healthcare support for cannabinoid therapies.
President Donald Trump has publicly confirmed that his administration is “considering” an executive order to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. Speaking to reporters on December 15, Trump stated, “We are looking at that very strongly,” according to Cannabis Business Times. This announcement follows last week’s reports of a […]
What Every Business Needs to Know January 1, 2026 marks a pivotal moment for Michigan’s cannabis industry as the controversial 24% wholesale tax takes effect, fundamentally reshaping the economics of the state’s second-largest cannabis market in the nation. The New Tax Landscape Michigan cannabis businesses face a seismic shift in their operating environment with the […]
What Businesses Need to Know About the New Framework Virginia lawmakers have taken a decisive step toward launching the South’s first recreational cannabis market, unveiling a revised framework that could see adult-use sales begin by November 2026. The proposal, detailed by the Virginia Mercury, represents a significant shift from previous attempts and includes several provisions designed […]
The cannabis industry faces another regulatory paradox. The Centers for Medicare & Medicaid Services (CMS) has proposed allowing Medicare Advantage plans to cover hemp-derived CBD products starting in 2027, potentially opening insurance reimbursement for millions of seniors. Yet this potential coverage window arrives just as a separate federal law threatens to make many of those same […]